The market for engineered living tissue is forecasted to exceed $4.8 billion by the year 2028. This report covers the many technologies through which they can be manufactured, including 3D bioprinting and 3D printing. Additionally, this report covers the key opportunities for engineered tissues, of which the regenerative medicine market is discussed in detail. The innovations in tissue engineering today will undoubtedly change the nature of healthcare of the future.